Individualisation of mycophenolate mofetil dose in renal transplant recipients

Author： van Hest Reinier M   Hesselink Dennis A   Vulto Arnold G   Mathot Ron AA   van Gelder Teun  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.4, 2006-03, pp. : 361-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Mycophenolic Acid: A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients

By de Winter Brenda C.M.  

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 827-838

Adis International

Access to resources Recommend Favorite

The use of mycophenolate mofetil in liver transplant recipients

By Detry Olivier   de Roover Arnaud   Delwaide Jean   Meurisse Michel   Honoré Pierre  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 11, 2003-11 ,pp. : 1949-1957

Informa Healthcare

Access to resources Recommend Favorite

Mycophenolate mofetil: Bronchiectasis (first report) in renal transplant recipients: 5 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1095, 2006-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Calcineurin inhibitors/mycophenolate mofetil/sirolimus: Proteinuria in renal transplant recipients: 7 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Ovarian and uterine cancer (first report for mycophenolate mofetil, sirolimus and tacrolimus) in renal transplant recipients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 23-24

Adis International

Access to resources Recommend Favorite